Qianyu Fu
Overview
Explore the profile of Qianyu Fu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fu Q, Zhou L, Fan Y, Liu F, Fan Y, Zhang X, et al.
Pak J Pharm Sci
. 2024 May;
37(1):33-41.
PMID: 38741398
The objective of this research is to assess how salvianolate impacts inflammation and oxidative stress in a laboratory setting, as well as to investigate the underlying mechanisms. HK-2 cells were...
2.
Fu Q, Zhou L, Fan Y, Liu F, Fan Y, Zhang X, et al.
BMC Cardiovasc Disord
. 2023 Nov;
23(1):544.
PMID: 37940879
The current study evaluated the effect of SGLT-2 inhibitor, dapagliflozin, on left ventricular remodeling in patients with type 2 diabetes and HFrEF. 60 patients were randomized (1:1) to receive dapagliflozin...
3.
Cheng L, Fu Q, Zhou L, Fan Y, Liu F, Fan Y, et al.
BMC Cardiovasc Disord
. 2022 Mar;
22(1):82.
PMID: 35246061
Objective: This study aimed to investigate the association between D-dimer and cardiovascular diseases outcomes in patients with type 2 diabetes. Methods: This is a single-center retrospective cohort study which was...
4.
Cheng L, Fu Q, Zhou L, Fan Y, Liu F, Fan Y, et al.
Sci Rep
. 2022 Mar;
12(1):3525.
PMID: 35241720
The current study evaluated the effect of SGLT-2 inhibitor, empagliflozin, on blood pressure reduction in Chinese elderly hypertension patients with type 2 diabetes and investigated its possible mechanisms. 124 patients...
5.
Cheng L, Fu Q, Zhou L, Fan Y, Liu F, Fan Y, et al.
Sci Rep
. 2021 Dec;
11(1):24263.
PMID: 34930986
The present study evaluated the effects of dapagliflozin, a SGLT2 inhibitor, or dapagliflozin plus metformin versus metformin monotherapy in patients with metabolic syndrome. This study included patients who admitted in...
6.
Xia Z, Li M, Tian Y, Li Y, Li B, Zhang G, et al.
ACS Chem Neurosci
. 2021 Jun;
12(12):2122-2132.
PMID: 34085811
Fermented soybean lipids (FSE-C) is an extract enriched in active lipid classes. To explore whether FSE-C can alleviate cognitive damage triggered by the exposure to microwave radiation through regulating lipid...